This indicates more significant diagnostic efficacies of TIPRL, LC3 and CD133 than the efficacy of CD46, previously reported in liver carcinogenesis, for an HCC incidence (Fig. 6h). Here, MAP1LC3A is linked to hepatocellular carcinoma.